Get started
Author

A. Van de Water

Observed names: A Van De Water, A Van de Water, A van de Water, A. V. D. WATER, A. VAN DE WATER, A. Van De Water, A. Water, ANDRE VAN DE WATER, An Van de Water, Andre Van de Water, André Van de Water
Institution: Galapagos (Belgium)
ORCID: 0000-0002-2802-3883
Observed ORCID: 0000-0002-2802-3883
OpenAlex ID: A5009440296
An improved method to correct the QT interval of the electrocardiogram for changes in heart rate
1989 · A. Van de Water, J. Verheyen, et al. · Journal of Pharmacological Methods · 319
Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic Antagonist
1988 · A. Van de Water, W. Janssens, et al. · Journal of Cardiovascular Pharmacology · 202
R 68 070: Thromboxane A2 Synthetase Inhibition and Thromboxane A2/Prostaglandin Endoperoxide Receptor Blockade Combined in One Molecule - II. Pharmacological Effects In Vivo and Ex Vivo
1989 · F De Clerck, J Beetens, et al. · Thrombosis and Haemostasis · 88
In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity
2002 · Fred De Clerck, André Van de Water, et al. · Fundamental and Clinical Pharmacology · 81
Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia.
1981 · W Flameng, W Daenen, et al. · Circulation · 79
PDF
In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation
2006 · Hua Rong Lu, Eddy Vlaminckx, et al. · European Journal of Pharmacology · 62
Cardiovascular effects of dl-nebivolol and its enantiomers — a comparison with those of atenolol
1988 · A. Van de Water, R. Xhonneux, et al. · European Journal of Pharmacology · 56
Nebivolol is devoid of intrinsic sympathomimetic activity
1989 · W.J. Janssens, A. Van de Water, et al. · European Journal of Pharmacology · 53
IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases
2023 · Stéphanie Lavazais, Manja Jargosch, et al. · Science Translational Medicine · 51
A new method to calculate the beat-to-beat instability of QT duration in drug-induced long QT in anesthetized dogs
2005 · H. van der Linde, A. Van de Water, et al. · Journal of Pharmacological and Toxicological Methods · 49
Cardioprotective effects of mioflazine during 1 h normothermic global ischaemia in the canine heart
1984 · W. FLAMENG, R. XHONNEUX, et al. · Cardiovascular Research · 45
Corrigendum to “In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation”
2007 · Hua Rong Lu, Eddy Vlaminckx, et al. · European Journal of Pharmacology · 32
Calmodulin Antagonist W‐7 Prevents Sparfloxacin‐Induced Early Afterdepolarizations (EADs) in Isolated Rabbit Purkinje Fibers: Importance of Beat‐to‐Beat Instability of the Repolarization
2006 · HUA RONG LU, EDDY VLAMINCKX, et al. · Journal of Cardiovascular Electrophysiology · 28
Both β-adrenergic receptor stimulation and cardiac tissue type have important roles in elucidating the functional effects of IKs channel blockers in vitro
2004 · H.R. Lu, E. Vlaminckx, et al. · Journal of Pharmacological and Toxicological Methods · 24
Selective vasoconstriction by alniditan in the carotid vascular bed of anaesthetized dogs
1996 · André Van de Water, Jan D'Aubioul, et al. · European Journal of Pharmacology · 14
Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
1991 · G Vandeplassche, C Hemans, et al. · Circulation Research · 13
Cardiovascular and some respiratory effects of high doses of alfentanil in dogs
1984 · Jan D'Aubioul, W. Van Gerven, et al. · European Journal of Pharmacology · 11
On-line computation of cardiac output with the thermodilution method, using a digital minicomputer
1976 · L. H. SNOECKX, J. L. VERHEYEN, et al. · Cardiovascular Research · 11
Cardiac and haemodynamic effects of intravenous administrations of flunarizine in closed-chest anaesthetized mongrel dogs.
1984 · K Kubo, A Van de Water, et al. · PubMed · 9
Cardiac and Hemodynamic Effects of Intravenous R80122, a New Phosphodiesterase III Inhibitor, in a Canine Model of Myocardial Ischemia and Heart Failure
1992 · André Van de Water, Raymond Xhonneux, et al. · Journal of Cardiovascular Pharmacology · 8
Antihypertensive activity of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935).
1975 · D Wellens, L Snoeckx, et al. · PubMed · 7
Prevention of the “no reflow” phenomenon in the canine heart by mioflazine
1985 · W. Flameng, R. Xhonneux, et al. · Basic Research in Cardiology · 6
Cardiovascular effects of ketanserin in closed-chest anesthetized dogs.
1985 · A van de Water, L Wouters, et al. · PubMed · 5
Comparative study of cardiovascular, neurological and metabolic side effects of 8 narcotics in dogs. Pethidine, piritramide, morphine, phenoperidine, fentanyl, R 39 209, sufentanil, R 34 995. III. Comparative study of the acute metabolic toxicity of the narcotics used in high and massive doses in curarised and mechanically ventilated dogs.
1979 · J de Castro, A Van de Water, et al. · PubMed · 4
Heparin knhances the synergism between platelet TXA2synthase inhibitioh/receptor blockade (ridogrel) and tissue plasminogen activator in lysing canine coronary thrombi
1991 · Andre Van de Water, Raymond Xhonneux, et al. · Journal of the American College of Cardiology · 2
PDF
Works count: 34
Citation count: 1,263
H-index: 14
I10-index: 18
Year
Topic
Type